The economic impact associated with cerebrovascular events related to non-valvular atrial fibrillation (NVAF) in Italy: the role of apixaban

The economic impact associated with cerebrovascular events related to non-valvular atrial fibrillation (NVAF) in Italy: the role of apixaban

Authors

  • Lorenzo Pradelli
  • Mario Calandriello
  • Roberto Di Virgilio
  • Marco Bellone
  • Marco Tubaro

DOI:

https://doi.org/10.7175/fe.v15i1s.972

Keywords:

Apixaban, Novel oral anticoagulant agents, Atrial fibrillation

References

Bollettino Ufficiale della Regione Veneto, 2010. Available at http://bur.regione.veneto.it/BurvServices/pubblica/HomeConsultazione.aspx

European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-429; http://dx.doi.org/10.1093/eurheartj/ehq278

Downloads

Published

2014-12-22

How to Cite

Pradelli, L., Calandriello, M., Di Virgilio, R., Bellone, M., & Tubaro, M. (2014). The economic impact associated with cerebrovascular events related to non-valvular atrial fibrillation (NVAF) in Italy: the role of apixaban. Farmeconomia. Health Economics and Therapeutic Pathways, 15(1S), 3–4. https://doi.org/10.7175/fe.v15i1s.972

Issue

Section

Editorial

Similar Articles

<< < 5 6 7 8 9 10 11 12 > >> 

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 3 4 5 6 7 > >> 
Loading...